SUNNY PHARMTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.55 TWD | -1.43% |
|
-1.61% | -20.03% |
| 18/04 | Sunny Pharmtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Sunny Pharmtech Inc.(TPEX:6676) added to S&P Global BMI Index | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 36Cr 1.12Cr 93Cr | Sales 2023 | 43Cr 1.33Cr 111.01Cr | Capitalization | 511.67Cr 16Cr 1.32TCr |
|---|---|---|---|---|---|
| Net income 2022 | -17Cr -52.86L -44Cr | Net income 2023 | -6.3Cr -19.59L -16Cr | EV / Sales 2022 | 8.42 x |
| Net Debt 2022 | 29Cr 90.65L 75Cr | Net Debt 2023 | 12Cr 37.55L 31Cr | EV / Sales 2023 | 12.2 x |
| P/E ratio 2022 |
-16.1
x | P/E ratio 2023 |
-78.3
x | Employees | 129 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 75.66% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.43% | ||
| 1 week | -1.61% | ||
| Current month | -3.33% | ||
| 1 month | -1.61% | ||
| 3 months | -14.44% | ||
| 6 months | -26.04% | ||
| Current year | -20.03% |
1 week
26.75
28.30
1 month
25.9529.70
Current year
25.9535.20
1 year
25.9545.20
3 years
17.3545.20
5 years
17.3545.20
10 years
17.3545.20
| Managers | Title | Age | Since |
|---|---|---|---|
Yung Lien Wu
CEO | Chief Executive Officer | - | 03/05/03 |
Chia Wei Chou
DFI | Director of Finance/CFO | - | 25/18/25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Charles Lin
BRD | Director/Board Member | - | 28/19/28 |
Yung Lien Wu
CEO | Chief Executive Officer | - | 03/05/03 |
Lien Tsu Li
BRD | Director/Board Member | - | 17/21/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/24/17 | 27.55 | -1.43% | 249,895 |
| 16/24/16 | 27.95 | -0.89% | 271,447 |
| 15/24/15 | 28.2 | +5.22% | 716,772 |
| 14/24/14 | 26.8 | -1.65% | 264,090 |
| 13/24/13 | 27.25 | -1.45% | 351,090 |
End-of-day quote Taipei Exchange, May 17, 2024
More quotes
Sunny Pharmtech Inc is a Taiwan-based company mainly engaged in the wholesale and sales of western medicines, as well as the research, development and manufacture of medicines. The main products include lectin drug complex (LDC) anesthesia analgesic ointment, neurofibrillary tangle (NFT) anti-urinary tract infection capsules, anti-mitochondrial antibody (AMA) hemostatic lozenges, cyclosporine A (CYA) injections for anemia and campto (CPT) gynecological injections. The Company's products are mainly sold to the United States.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -20.03% | 13Cr | |
| +32.09% | 69TCr | |
| +29.39% | 59TCr | |
| -1.34% | 37TCr | |
| +20.34% | 33TCr | |
| +7.39% | 29TCr | |
| +14.25% | 24TCr | |
| -3.03% | 21TCr | |
| +10.02% | 21TCr | |
| +8.49% | 17TCr |
- Stock Market
- Equities
- 6676 Stock
